MentionFox
Home › Stakes › Akero Therapeutics, Inc.
5%+ stakes · Schedule 13D and 13G

Akero Therapeutics, Inc.: 5%+ holders

Who has reported owning 5% or more of Akero Therapeutics, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more0
Filings11
Latest filing2026-02-17

Akero Therapeutics, Inc. has 11 Schedule 13D or 13G filings on record since 2025-08-12. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
T. Rowe Price Associates, Inc.4.8%3,810,076SCHEDULE 13G/A, 2025-11-142025-09-30
Janus Henderson Group Plc4.1%3,397,779SCHEDULE 13G/A, 2026-02-172025-12-31
Wellington Management Group LLP0%0SCHEDULE 13G/A, 2026-02-102025-12-31
RTW Investments, LP0%0SCHEDULE 13G/A, 2026-02-172025-12-31
Deep Track Capital, LP0%0SCHEDULE 13G/A, 2026-02-132025-12-31

Timeline

FiledHolderPercentFiling
2025-08-12Wellington Management Group LLP4.3%SCHEDULE 13G/A
2025-08-14Janus Henderson Group Plc8.5%SCHEDULE 13G/A
2025-08-14RTW Investments, LP7.3%SCHEDULE 13G/A
2025-10-07Deep Track Capital, LP5.5%SCHEDULE 13G
2025-11-12Wellington Management Group LLP5.3%SCHEDULE 13G
2025-11-14T. Rowe Price Associates, Inc.4.8%SCHEDULE 13G/A
2025-11-14Janus Henderson Group Plc7.9%SCHEDULE 13G/A
2026-02-10Wellington Management Group LLP0%SCHEDULE 13G/A
2026-02-13Deep Track Capital, LP0%SCHEDULE 13G/A
2026-02-17Janus Henderson Group Plc4.1%SCHEDULE 13G/A
2026-02-17RTW Investments, LP0%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Akero Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/akero-therapeutics
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Akero Therapeutics, Inc. 5%+ holders: stakes filed. MentionFox, 2026-09-27. https://mentionfox.com/stakes/akero-therapeutics